COGENT BIOSCIENCES INC (COGT:NASDAQ)

$33.52 0.45 (1.3607%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 80

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed COGENT BIOSCIENCES INC (COGT:NASDAQ) News Sources

What to Know About This Fund's $6.6 Million UroGen Sale After a 600% Stock Surge

23-05-2026

fool.com

Assessing Cogent Biosciences (COGT) Valuation After A Strong Year And Recent Share Price Pullback

26-05-2026

yahoo.com

Cogent Biosciences Announces FDA Acceptance of New Drug Application (NDA) with Priority Review for Bezuclastinib in Combination with Sunitinib for Patients with GIST

28-05-2026

yahoo.com

Cogent Biosciences Announces Detailed Clinical Data from PEAK Phase 3 Trial with Bezuclastinib in Combination with Sunitinib in Gastrointestinal Stromal Tumors (GIST) at 2026 American Society of Clinical Oncology (ASCO) Annual Meeting

30-05-2026

yahoo.com

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter

31-05-2026

fool.com

Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now?

07-06-2026

yahoo.com

How Investors May Respond To Cogent Biosciences (COGT) Priority Review For Bezuclastinib GIST Regimen

10-06-2026

yahoo.com

Cogent Biosciences Announces Detailed Data from APEX Pivotal Trial of Bezuclastinib in Patients with Advanced Systemic Mastocytosis at the 2026 European Hematology Association (EHA) Congress

12-06-2026

yahoo.com

Cogent Biosciences Announces Preclinical Data from Novel JAK2 V617F Inhibitor at the 2026 European Hematology Association (EHA) Congress

12-06-2026

yahoo.com

Cogent Biosciences' Potential Rare Blood Disease Treatment Meets Endpoints in Clinical Trial

12-06-2026

yahoo.com

COGENT BIOSCIENCES INC (COGT:NASDAQ) Sentiment Trend

0 25 50 75 100 91 57 76 79 77 91 85 77 77 88 23-05-2026 26-05-2026 28-05-2026 30-05-2026 31-05-2026 07-06-2026 10-06-2026 12-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

COGENT BIOSCIENCES INC (COGT:NASDAQ) FAQs

toggle

What is the current price of COGENT BIOSCIENCES INC (COGT:NASDAQ)?

The current price of COGENT BIOSCIENCES INC (COGT:NASDAQ) is $33.52.


toggle

COGENT BIOSCIENCES INC (COGT:NASDAQ) absolute price change since previous trading day?

The absolute price change of COGENT BIOSCIENCES INC (COGT:NASDAQ) since the previous trading day is $0.45.


toggle

COGENT BIOSCIENCES INC (COGT:NASDAQ) percentage price change since previous trading day?

The percentage price change of COGENT BIOSCIENCES INC (COGT:NASDAQ) since the previous trading day is 1.3607%.


toggle

What is the most recent average sentiment score for COGENT BIOSCIENCES INC (COGT:NASDAQ)?

The most recent average sentiment score for COGENT BIOSCIENCES INC (COGT:NASDAQ) is 80 out of 100.


toggle

What is the most recent average sentiment for COGENT BIOSCIENCES INC (COGT:NASDAQ)?

The most recent sentiment for COGENT BIOSCIENCES INC (COGT:NASDAQ) is .


SEC-8K** Filing Available For COGENT BIOSCIENCES INC (COGT:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.